Search

everythinglearnresearchcommunity

for

Search:↓

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

There's no link between low iron levels and the hair loss condition, alopecia areata.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

HLA-DRB5 and other genes may be linked to alopecia universalis.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

The document concludes that proper diagnosis and management of hair loss in children require a detailed examination and understanding of various hair disorders.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Follicular Unit Extraction (FUE) is a popular hair transplant method with minimal scarring that can transplant many grafts quickly and improve appearance and psychological well-being.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.